Five Actinobacillus pleuropneumoniae strains isolated from pathological lesions of porcine pleuropneumonia in Hungary could not be assigned to any of the accepted 15 serovars. Using hyperimmune serum raised against these untypable-serovar A. pleuropneumoniae strains in rabbits, indirect haemagglutination tests proved that they form a distinct group and there is no cross-reaction between them and the type strains of A. pleuropneumoniae. All five strains harboured the toxin-associated genes for the production (apxIA) and secretion (apxIB) of ApxI, the gene for the expression of ApxII and the largest-size (2800 bp) apxIV gene. The carbon source utilisation pattern and the sequence analysis of the 16S rRNA gene confirmed the species identification of the suggested type strain, A. pleuropneumoniae A-85/14. A new serovar of A. pleuropneumoniae -serovar 16 -is proposed with A. pleuropneumoniae A-85/14 as reference strain.
Acta Veterinaria Hungarica 63, 2015 On the basis of surface soluble capsular polysaccharide (CPS) and lipopolysaccharide (LPS) antigens, 15 serovars have been described (Nielsen, 1986a,b; Fodor et al., 1989; Nielsen et al., 1997; Blackall et al., 2002) . Several methods have been used for serotyping A. pleuropneumoniae strains; these include slide agglutination, latex agglutination, complement fixation, indirect haemagglutination (IHA), coagglutination, ring precipitation and agar gel precipitation tests (Mittal et al., 1983a; Mittal et al., 1987; Molnár, 1990; Nielsen et al., 1997) . Many authors have found that among the classical serotyping methods the IHA test is the most specific and sensitive (Mittal et al., 1983b; Nicolet et al., 1981; Nielsen and O'Connor, 1984; Nicolet, 1988) . Cross-reactions make serotyping rather difficult, and such cross-reactions have been reported between serovars 1, 9 and 11, serovars 3, 6 and 8, and serovars 4 and 7 (Mittal et al., 1988; Zhou et al., 2008) . Correlation between serovars and the virulence of A. pleuropneumoniae strains was described several years ago (Marsteller and Fenwick, 1999) , which can be explained by the correlation between serovars and the pattern of toxin production (Kamp et al., 1994; Frey et al., 1995) . On the basis of this correlation, classical serotyping methods are nowadays frequently replaced by the detection of toxin genes; however, the latter can be misguiding in the case of strains with atypical toxin production (Rayamajhi et al., 2005; Gottschalk, 2015) . More specific molecular serotyping methods detect genes involved in the biosynthesis of capsular polysaccharides Bossé et al., 2014; Marois-Crehan et al., 2014; Turni et al., 2014) . Using amplified fragment length polymorphism (AFLP) analysis 20 clusters could be identified, and all clusters contained strains of a single serotype (Kokotovic and Angen, 2007) .
Between 2012 and 2014, a total of 50 A. pleuropneumoniae strains isolated from clinical cases from different swine farms in Hungary were serotyped by the IHA test (data not presented), but five strains could not be assigned to any of the 15 known serovars of A. pleuropneumoniae. The aim of the present study was to examine these untypable strains and to present evidence about the existence of a new serovar of A. pleuropneumoniae, serovar 16.
Materials and methods

Bacteria
Five A. pleuropneumoniae field isolates of biotype 1 were included in the present study. Two of them were isolated from the lungs of slaughtered pigs showing typical lesions of pleuropneumonia. Three strains were isolated from postmortem cases of acute porcine pleuropneumonia, submitted to our laboratory from different swine farms. The strains originated from five different farms located in different parts of Hungary, with epidemiological connection existing only between two of them (some animals were transported from one farm to the Acta Veterinaria Hungarica 63, 2015 other). The reference strains of all 15 serovars of A. pleuropneumoniae were kindly provided by Dr. O. Angen (Danish Veterinary Laboratory, Copenhagen).
The A. pleuropneumoniae strains were isolated on Tryptone Soya Agar (TSA, Biolab Ltd. Budapest, Hungary) cross-inoculated with Staphylococcus aureus, and cultured on chocolate agar with added 50 μg/ml NAD (Biolab Ltd., Budapest, Hungary), both containing 10% defibrinated sheep blood. Cultures were incubated at 37 °C for 24 h in aerobic environment with the addition of 5% carbon dioxide. They were identified using standard methods (Barrow and Feltham, 1993) . After identification, the isolated A. pleuropneumoniae strains were stored at -80 °C until further examination.
Production of antisera
Antisera were produced in rabbits against A. pleuropneumoniae reference strains of serovars 1-15 and against our five field strains as described by Biberstein (1978) . Briefly, rabbits weighing about 3 kg were inoculated intravenously with one of the A. pleuropneumoniae strains. Bacteria from three chocolate agar cultures, incubated at 37 °C for 24 h, were suspended in 40 ml saline (approximately 3 × 10 10 colony-forming units/ml) containing 0.5% formaldehyde. The suspension was allowed to stand at room temperature for 1 h, and then the bacterial cells were pelleted by centrifugation, resuspended in saline, and stored at 4 °C until used. The rabbits were inoculated intravenously with 0.5, 1, 2, 3, 3 and 3 ml of the suspension, respectively, 3-4 days apart. One week after the last injection, they were bled in general anaesthesia induced with ketamine and xylazine (Animal Experiment Licence No. 22.1/2703/003/2009). Sera were harvested and stored in small aliquots in a deep freezer at -20 °C until used.
Serological characterisation
The IHA test was performed as described by Biberstein (1978) . All antisera produced against the 15 type strains of A. pleuropneumoniae and the five untypable A. pleuropneumoniae strains were examined with all type strains and the 5 untypable A. pleuropneumoniae strains. Reactions below a titre of 1:160 were neglected.
Detection of toxin genes by polymerase chain reaction (PCR)
The presence of apxIA, apxIB, apxII, apxIII and apxIV genes was examined using PCR. The primers and conditions for these PCR assays had been described by Rayamajhi et al. (2005) .
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Characterisation of A. pleuropneumoniae strain A-85/14
After the serological examinations, the biochemical characteristics and the nucleotide sequence of the 16S rRNA gene of a representative strain, A. pleuropneumoniae A-85/14 were determined. The utilisation of 95 carbon sources was examined using the Biolog system (BIOLOG Inc., California). The 16S rRNA gene was amplified by PCR using the universal primers, its nucleotide sequence was determined as described (Relman, 1993) , and the rrs gene sequence was submitted to the GenBank database (Accession No. SUB1098860 A-85/14 KT763387).
Results
Using conventional methods, all five isolates proved to be A. pleuropneumoniae biotype 1 strains. They did not show any reactions with antisera raised against the 15 recognised type strains of A. pleuropneumoniae in the IHA test but they reacted with their homologous sera in titres of 1:2560 and 1:5120. All the five strains gave heterologous reactions in the same titre with the hyperimmune sera raised against the other four untypable A. pleuropneumoniae strains. None of the 15 type strains of A. pleuropneumoniae gave a reaction with the sera raised against the untypable A. pleuropneumoniae strain A-85/14.
All five strains harboured the genes for the production (apxIA) and secretion (apxIB) of ApxI, the gene for the expression of ApxII and the largest-size (2800 bp) apxIV gene.
Based upon the utilisation of 95 carbon sources, A. pleuropneumoniae strain A-85/14 was identified as A. pleuropneumoniae, as its carbon utilisation pattern showed 99% similarity with the database. Sequence analysis of the 16S rRNA detected 99% similarity with A. pleuropneumoniae (GenBank Accession No. SUB1098860 A-85/14 KT763387).
The A. pleuropneumoniae strain A-85/14 has been deposited in the Hungarian National Collection of Medical Bacteria (HNCMB) under the registration number of 96705.
Discussion
The five Hungarian isolates included in the present study were examined by the IHA test using hyperimmune sera raised against the 15 accepted serovars of A. pleuropneumoniae. As these strains did not show any reaction with the type sera, they proved to be untypable. Hyperimmune sera were produced in rabbits against the five untypable strains, and all these antisera showed both homologous and heterologous reactions of high titre within this group. None of the 15 type strains reacted with the sera produced against the untypable strains. Consequently, the five, formerly untypable A. pleuropneumoniae strains represent a common and distinct serovar of A. pleuropneumoniae. Untypable A. pleuropneumoniae strains can be isolated from clinical samples; some of them could be allocated in clusters together with serotypable ones indicating loss of typespecific capsule polysaccharides (Kokotovic and Angen, 2007) . In the case of our strains the capsule material was present and antibodies could be raised against them, so the cause of their being untypable was not the loss of antigens. Kokotovic and Angen (2007) described two clusters containing only untypableserovar A. pleuropneumoniae strains, and they supposed that these untypable strains could represent additional serovars. Further investigations can reveal whether our strains belong to one of these clusters.
Four toxin genes, apxIA, apxIB, apxII and apxIV (2800 bp), were detected in all five strains; they can express ApxI and ApxII but not ApxIII, while ApxIV can be produced in vivo only (Schaller et al., 1999) . This toxin gene pattern is typical of A. pleuropneumoniae serovars 5a and 5b (Rayamajhi et al., 2005) . Using the IHA test, A. pleuropneumoniae serovars 5a and 5b did not react with antisera produced against the five untypable strains, so they do not belong to serovar 5a or 5b. The discrepancy between the results of the IHA test and serotyping based on the detection of toxin genes can be explained by the fact that the latter method does not detect genes responsible for antigen production; rather, it is based on the correlation between certain serovars and toxin production of the A. pleuropneumoniae strains. Although new molecular methods are widely used for serotyping A. pleuropneumoniae (Rayamajhi et al., 2005; Bossé et al., 2014; Marois-Crehan et al., 2014; Turni et al., 2014; Gottschalk, 2015) , they cannot always replace traditional serotyping tests.
The results of utilisation of 95 carbon sources and the sequence analysis of the 16S rRNA gene confirmed that the representative A. pleuropneumoniae A-85/14 strain is a typical A. pleuropneumoniae.
Among the five A. pleuropneumoniae biotype 1 strains which proved to be untypable using hyperimmune sera raised against the 15 type strains of A. pleuropneumoniae, a new serovar was identified, represented by strain A-85/14, and all the five untypable A. pleuropneumoniae strains of our collection belong to this serovar. This serovar can be clearly differentiated from the other 15 serovars of A. pleuropneumoniae by IHA.
In conclusion, this newly characterised serovar represents a distinct serovar, and we recommend that it be designated as serovar 16 of A. pleuropneumoniae with A. pleuropneumoniae A-85/14 strain as the type strain. The recommended type strain has been deposited in the HNCMB under the accession number of 96705, and its rrs gene sequence has been submitted to GenBank (Accession No. SUB1098860 A-85/14 KT763387).
